To start your customized experience click the start button
Customize ?  
Cancer Types
Quick Links
Award Programs
About Us
Contact Us
Privacy Policy
Terms & Conditions
Face Book
Cure Media Group, LLC.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873

Copyright © 2019
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.


Ian Macleod
“At 34, I have another chance to live the rest of my life with a consciousness that there's great purpose in the pain.”
Conor Killmurray
From a care team giving a patient with metastatic breast cancer a taste of Paris after a planned trip had to be canceled to a local group of veterans honoring one of their own after a lung cancer diagnosis, here’s what’s making the headlines in the cancer space this week.
Dr. Mazyar Shadman
“If I only have one tool to treat the disease, I will play with that tool in many different ways. But if I have access to four different tools, then I will give up tool (number) one if I don't feel it's working,” explained Dr. Mazyar Shadman of the Seattle Cancer Care Alliance, about his approach to treating high-risk chronic lymphocytic leukemia in an interview with CURE®.
Conor Killmurray
From the National Cancer Institute launching a nationwide study of patients with cancer who either have COVID-19 or are being tested for it to understand the disease to “St. Elmo’s Fire” and “Batman and Robin” director Joel Schumacher passing away from cancer, here’s what’s making the headlines in the cancer space this week.
Dr. Guillermo Garcia-Manero
The phase 3 trial evaluating eprenetapopt plus Vidaza completed enrollment recently, and could lead to a new standard of care with positive results, according to Dr. Guillermo Garcia-Manero.
Ryan McDonald
The Food and Drug Administration (FDA) extended the indication of Mylotarg (gemtuzumab ozogamicin) to include the treatment of children aged one month or older with newly diagnosed CD33-positive acute myeloid leukemia (AML).
Conor Killmurray
From the American Cancer Society laying off 1,000 employees due to the economic impact of COVID-19 to former Senate Majority Leader Harry Reid announcing his cancer is in remission after receiving an experimental treatment, here’s what’s making the headlines in the cancer space this week.
Jessica Skarzynski
Here is a roundup of the latest news and updates for patients with Chronic Lymphocytic Leukemia from CURE.
Ryan McDonald
“The superior efficacy of venetoclax-obinutuzumab has been observed and maintained in the current follow up,” Dr. Othman Al-Sawaf, of University Hospital of Cologne in Germany, said during a pre-recording presentation at the 2020 ASCO Virtual Scientific Program.
Ryan McDonald
“Collectively, these results support acalabrutinib (Calquence) use in upfront CLL,” said Dr. John C. Byrd. “This is compounded and supported by two additional phase III studies that have been completed with this agent.”

Sign In

Not a member? Sign up now!
Continue without login